Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea
Ran-hui Cha, Shin Wook Kang, Cheol Whee Park, Dae Ryong Cha, Ki Young Na, Sung Gyun Kim, Sun Ae Yoon, Sejoong Kim, Sang Youb Han, Jung Hwan Park, Jae Hyun Chang, Chun Soo Lim, Yon Su Kim
Kidney Res Clin Pract. 2017;36(1):68-78.   Published online 2017 Mar 31     DOI: https://doi.org/10.23876/j.krcp.2017.36.1.68
Citations to this article as recorded by Crossref logo
Serum VEGF-D level is correlated with renal dysfunction and proteinuria in patients with diabetic chronic kidney disease
Thi Thuy Uyen Nguyen, Hyeongwan Kim, Yoon Jung Chae, Jong Hwan Jung, Won Kim
Medicine.2022; 101(7): e28804.     CrossRef
Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
Solène M. Laville, Ziad A. Massy, Said Kamel, Jean Marc Chillon, Gabriel Choukroun, Sophie Liabeuf
Toxins.2021; 13(2): 91.     CrossRef
Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease
Mónica Faria, Maria Norberta de Pinho
Translational Research.2021; 229: 115.     CrossRef
Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial
Youn Kyung Kee, Sang Youb Han, Duk-Hee Kang, Jung Woo Noh, Kyung Hwan Jeong, Gheun-Ho Kim, Yang Wook Kim, Beom Seok Kim
Yonsei Medical Journal.2021; 62(1): 41.     CrossRef
Reduction of protein‐bound uraemic toxins in plasma of chronic renal failure patients: A systematic review
V. Saar‐Kovrov, W. Zidek, S. Orth‐Alampour, D. Fliser, V. Jankowski, E. A. L. Biessen, J. Jankowski
Journal of Internal Medicine.2021; 290(3): 499.     CrossRef
Effect of Renamezin upon attenuation of renal function decline in pre-dialysis chronic kidney disease patients: 24-week prospective observational cohort study
Hayne Cho Park, AJin Cho, Do Hyoung Kim, Kyu-sang Yun, Juhee Kim, Eun Young Lee, Sang Kyung Jo, So-Young Lee, Kum Hyun Han, Yoon Kyung Chang, Dong-Jin Oh, Young-Ki Lee, Hayato Iwase
PLOS ONE.2021; 16(6): e0252186.     CrossRef
Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials
Pei-Yu Su, Ya-Han Lee, Li-Na Kuo, Yen-Cheng Chen, Chiehfeng Chen, Yi-No Kang, Elizabeth H. Chang
Frontiers in Pharmacology.2021;[Epub]     CrossRef

Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease

Daisuke Nagata, Hiromichi Yoshizawa
International Journal of Nephrology and Renovascular Disease.2020; Volume 13: 359.     CrossRef
The clinical impact of gut microbiota in chronic kidney disease
So Mi Kim, Il han Song
The Korean Journal of Internal Medicine.2020; 35(6): 1305.     CrossRef
Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome
Maaike K. van Gelder, Igor R. Middel, Robin W. M. Vernooij, Michiel L. Bots, Marianne C. Verhaar, Rosalinde Masereeuw, Muriel P. Grooteman, Menso J. Nubé, M. A. van den Dorpel, Peter J. Blankestijn, Maarten B. Rookmaaker, Karin G.F. Gerritsen
Toxins.2020; 12(4): 234.     CrossRef
Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients
Mayumi Asai, Sei Kumakura, Mami Kikuchi
Renal Failure.2019; 41(1): 47.     CrossRef
Framingham risk score and risk of incident chronic kidney disease: A community-based prospective cohort study
Changhyun Lee, Hae-Ryong Yun, Young Su Joo, Sangmi Lee, Joohwan Kim, Ki Heon Nam, Jong Hyun Jhee, Jung Tak Park, Tae-Hyun Yoo, Shin-Wook Kang, Seung Hyeok Han
Kidney Research and Clinical Practice.2019; 38(1): 49.     CrossRef
Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects
Tomohisa Shibata, Yuki Nomura, Akitsugu Takada, Mai Ueno, Masataka Katashima, Rie Yazawa, Kenichi Furihata
Clinical Pharmacology in Drug Development.2019; 8(3): 304.     CrossRef
Prediction of Patients Who Can Benefit from Oral Intestinal Sorbent AST-120
Ran-hui Cha
Journal of Korean Medical Science.2019;[Epub]     CrossRef
Effects and Safety of an Oral Adsorbent on Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis
Ying-Chun Chen, Mei-Yi Wu, Ping-Jen Hu, Tzu-Ting Chen, Wan-Chen Shen, Wei-Chiao Chang, Mai-Szu Wu
Journal of Clinical Medicine.2019; 8(10): 1718.     CrossRef
Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β2-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis—Oshima Award Address 2016
Suguru Yamamoto
Clinical and Experimental Nephrology.2019; 23(2): 151.     CrossRef
Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
Raymond Vanholder, Steven Van Laecke, Griet Glorieux, Francis Verbeke, Esmeralda Castillo-Rodriguez, Alberto Ortiz
Toxins.2018; 10(6): 237.     CrossRef
Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease
Ki Heon Nam, Hae-Ryong Yun, Young Su Joo, Joohwan Kim, Sangmi Lee, Changhyun Lee, Kyoung Sook Park, Jung Tak Park, Tae-Ik Chang, Ea Wha Kang, Tae-Hyun Yoo, Shin-Wook Kang, Seung Hyeok Han
Diabetes, Obesity and Metabolism.2018; 20(12): 2778.     CrossRef
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
Gerald Schulman, Tomas Berl, Gerald J. Beck, Giuseppe Remuzzi, Eberhard Ritz, Miho Shimizu, Mami Kikuchi, Yuko Shobu
Clinical and Experimental Nephrology.2018; 22(2): 299.     CrossRef
Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction
Hideki Fujii, Shunsuke Goto, Masafumi Fukagawa
Toxins.2018; 10(5): 202.     CrossRef
Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment?
Angelika Bazyluk, Jolanta Malyszko, Edyta Zbroch
Postgraduate Medicine.2018; 130(5): 461.     CrossRef
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
Wen-Chih Liu, Yasuhiko Tomino, Kuo-Cheng Lu
Toxins.2018; 10(9): 367.     CrossRef
Importance of AST-120 (Kremezin®) Adherence in a Chronic Kidney Disease Patient with Diabetes
Yasuhiko Tomino, Atsuko Hisada-Urita, Takuto Seki, Tomonari Watanabe, Reo Kanda, Toshimasa Takahashi
Case Reports in Nephrology and Dialysis.2018; 8(2): 107.     CrossRef